University Of California San Francisco

Novel therapeutic approaches and a robust drug pipeline may provide hope for patients with Sjögren’s syndrome, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

Women diagnosed with COVID-19 while pregnant, particularly those with other comorbidities, had a higher risk for very preterm birth, preterm birth and early-term birth, a population-based study showed.

Laws in 23 states that capped the number of days a Medicare enrollee could receive an initial opioid prescription may have had their intended effect, a recent study showed.

NephroSant, a startup operating out of the University of California, San Francisco that developed a test to detect graft rejection following kidney transplantation, has hired Gina Ford, RPh, MBA, as its new chief commercialization officer.

Approximately 50% of women experiencing homelessness or unstable housing during the COVID-19 pandemic had depression or anxiety symptoms, according to study results in a research letter published in JAMA Network Open.

The Mayo Clinic in Rochester, Minnesota, was named the No. 1 hospital in the United States for pulmonology and lung surgery in U.S. News & World Report’s 2021-2022 Best Hospitals rankings and ratings.

Higher circulating levels of the protein CTRP9 are associated with worse lung function in patients with systemic sclerosis-related interstitial lung disease, according to data published in Arthritis Care & Research.

Increasing amounts of habitual coffee consumption were inversely linked with a lower risk for arrhythmia, according to a prospective cohort study of nearly 400,000 adults in the United Kingdom.

Despite the increasing number of women entering academic internal medicine, researchers found that “substantial salary inequities persist at the highest faculty levels and specifically in procedural-based specialties.”

The American College of Rheumatology has released three new vasculitis treatment guidelines — for ANCA-associated vasculitis, giant cell arteritis and Takayasu arteritis, and polyarteritis nodosa — with a fourth expected soon.